A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors

Mass General Brigham

Status: Active, not recruiting

Conditions: Cancer

Treatments: Other: Waitlist control; Other: 3RP-AYA

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT03768336

1K07CA211955-01A1 (U.S. NIH Grant/Contract)

18-428

Details and patient eligibility

About

This research study aims to explore the feasibility and acceptability of an adapted resiliency group program, called the Relaxation Response Resiliency Program (3RP-AYA), to reduce stress and promote stress-management among adolescents and young adults who have completed treatment for cancer.

Full description

The Relaxation Response Resiliency Program, or 3RP, was developed by researchers at the MGH Benson-Henry Institute for Mind Body Medicine. The 3RP is a group program that-through a variety of mind-body approaches, such as imagery, relaxation, and yoga-seeks to buffer stress and promote psychological resiliency and physical well-being.

The 3RP has not yet been carried out with adolescent or young adult individuals who have recently completed treatment for cancer. As such, the investigators have adapted the original 3RP to target the specific needs of adolescent and young adult patients who are transitioning off active treatment. The investigators are conducting this study to see if the adapted program, the 3RP-AYA, is effective at reducing stress and stress-related symptoms for people of at least age 16 who have completed treatment for cancer within the past five years.

Enrollment: 72 patients

Sex: All

Ages: 16 to 29 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with any cancer between ages 14 and 29
• Completed cancer treatment within the past 5 years
• At least 16 years of age at time of enrollment

Exclusion criteria

• Unwilling or unable to participate in the study
• Unable to speak or read English
• Is medically or otherwise unable to participate (as determined by a physician or study PI)
• Unwilling or unable to participate in study sessions delivered via the Partners Telehealth videoconferencing software
• Participation in a focus group during Phase 1 (DF/HCC 17-315)

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

72 participants in 2 patient groups

Waitlist Control

Active Comparator group

Description:

* The 3RP-AYA will be delivered in weekly sessions over the course of approximately 8 weeks, for a total of 8 sessions * Mini relaxation practice * Weekly goal check-ins * RR-practice

Treatment:

Other: Waitlist control

3RP Group Sessions

Experimental group

Description:

* The 3RP-AYA will be delivered in weekly sessions over the course of approximately 8 weeks, for a total of 8 sessions * Mini relaxation practice * Weekly goal check-ins * RR-practice

Treatment:

Other: 3RP-AYA